Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction.
Alabama hospitals reported 557 COVID deaths in the 10 days ending Tuesday. Monoclonal antibody treatments can cut the need to hospitalize a COVID patient...